Iraq vs Mongolia: Tuberculosis patients living with HIV receiving antiretroviral therapy
Iraq
2 patients
in 2021
Mongolia
2 patients
in 2021
Iraq rank
125th
Mongolia rank
125th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Iraq
- Mongolia
How they compare
Iraq currently reports 2 patients against 2 patients in Mongolia, a difference of 0 patients.
The two have swapped places 2 times across 16 shared years of data; in 2006 it was Mongolia ahead.
Iraq ranks 125th and Mongolia ranks 125th of 183 countries.
Mongolia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iraq | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 patients | 0.75 patients | 0.75 patients | Mongolia |
| 2010s | 0.6 patients | 3.8 patients | 3.2 patients | Mongolia |
| 2020s | 1.5 patients | 3 patients | 1.5 patients | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Iraq or Mongolia?
- Iraq, at 2 patients against 2 patients in Mongolia as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Iraq and Mongolia?
- 0 patients, with Iraq ahead.
- How many years of comparable data are there for Iraq and Mongolia?
- 16 years are reported by both, from 2006 to 2021.
- How do Iraq and Mongolia rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Iraq ranks 125th and Mongolia ranks 125th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.